Cytel Inc. has launched East On Demand offered via the cloud and licensed through subscriptions, providing statisticians with more flexible access to East, the industry standard software package for the effective design of adaptive and innovative clinical trials.

East On Demand provides access to clinical design and analysis features for a wider audience, including companies that have less frequent or short-term requirements. Customers that are implementing a smaller number of clinical trials can ensure they pay only for what they need, with flexible monthly subscriptions and a range of purpose-built toolkits designed for specific clinical trial protocols and therapeutic areas.

Anne Pelz, vice president of Product Management at Cytel said, “Smaller biotechnology companies face a unique set of challenges when it comes to the clinical development process. They are often working with tight budgets, have limited IT infrastructure for setting up and maintaining software environments, and typically require trial designing capabilities for a much shorter period. They will also benefit most from an optimized adaptive trial design approach because these methodologies allow for the generation of compelling data from small patient groups while significantly reducing overall development costs and risk of trial failure. Cytel has thus ensured that East On Demand offers a holistic solution for the smaller biotech, delivering the full arsenal of adaptive design tools in a way that is optimally accessible for them.”